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Abstract We report the molecular cloning of the human laminin 
oc3b chain variant and its mRNA expression pattern in adult 
human tissues when compared to the a3a variant. The mRNA 
encoding for the o3b variant is about 11 kb and the predicted 
translation product carries the complete set of domains typical 
for a 'full-sized' laminin a chain. Apart from the similar domain 
structure of rx3b also the sequence of rx3 resulted more closely 
related to the a5 than to the oc4 chain. Quantitative analysis of 
the RNA expression in a broad panel of adult human tissues 
indicated that the rx3b variant is more widely distributed than the 
oc3a shorter variant. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Laminins are large cruciform heterotrimeric basement 
membrane glycoproteins mediating multiple structural and 
cellular functions [1]. The heterotrimer is composed of genet-
ically distinct but homologous chains denominated a, ß and y 
[2] which assemble via ionic interactions mediated with high 
specificity by their coiled-coil domains I and II. Up to date, 
three ß, ßl, ß2, and ß3 [3-7], two y, yl and y2 [8-11] and six a, 
a l , oc2, cc3, a4, a5, and ocD [12-26] chains have been de-
scribed. Common to all the a chains is a unique C-terminus 
folding into a large globular structure, constituted of five so-
called G domains. These are the primary regions of molecular 
interaction of laminin with other extracellular matrix mole-
cules and with cell surface receptors. The a l , oc2, ct5, and 
a D chains have been defined as 'full-sized', as opposed to 
the a3 and oc4 chains which are classified as truncated due 
to their lack of an extended NH2-terminal region. Each a 
chain can combine with different ß and y chains to form at 
least 11 different heterotrimeric laminin isoforms. The oc3 
chain assembles with ß3 and y2 chains to form laminin 5 
[27], with ßl and yl chains to originate laminin 6 and with 
ß2 and yl to form laminin 7 [28]. Laminin 5, previously de-
noted epiligrin/kalinin/nicein [29-31], is a major cell ligand in 
the basement membranes of specialized epithelia where it is 
integrated via laminins 6 and 7 [28]. The G domain of the oc3 
chain binds the hemidesmosome via the oc6ß4 integrin [32] and 
mutations in each of the laminin 5 chains are associated with 
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junctional forms of epidermolysis bullosa [33]. The a3 chain 
gene has been reported to give rise to two distinct transcripts 
[19], now denominated oc3a and oc3b in man and oc3A and 
ct3B in the mouse [34], which display a variable NH2-terminal 
region. The shorter transcript, oc3a, encoded for a 5,5 kb 
mRNA, whereas the longer transcript, oc3b, is suggested to 
encode for messages of apparently distinct lengths between 
the two species. 
In this study we report a novel nucleotide sequence of the 
human a3b that shows that this laminin chain variant has a 
NH2-terminal domain organization like the full-sized laminin 
a chains. At the mRNA level the two oc3 isoforms display a 
distinct pattern of expression, with the oc3b mRNA having a 
wider tissue distribution compared to a3a. 
2. Materials and methods 
2.1. RT-PCR and nucleotide sequencing 
Degenerate primers were designed based on the sequences of do-
mains VI and V of the murine laminin oe5 chain [25] relying upon the 
high degree of interchain homology in these domains. Three degener-
ate primers (sense: deg-1 5' AT(ACT)CA(GA)GG(AGCT)CA(GA)-
TA(TC)TG(TQGA 3' and antisense: deg-2 5' GC(GA)TG(AGC-
T)CC(GA)TG(AG)CA(GA)TT(AG)CA 3' and deg-3 5' (TC)T-
C(AG)CA(AG)(TA)A(AGCT)GG(AG)AA(GA)TT(AG)TA 3') were 
used to amplify fragments from total RNA of HUVEC cells or of 
the human fibrosarcoma cell line HS-913T. The amplification prod-
ucts were cloned into the pGEM-T vector (Promega Corp.) and se-
quenced by the chain termination method using the Sequenase kit (US 
Biochemical Corp.). To determine the sequence extending towards the 
ATG start codon, we applied the RACE method, using the 5'-3' 
RACE kit (Boehringer), primer 3 (in RT), primer 4 (first PCR) and 
primer 5 (nested PCR). To determine the sequence of the mouse a3B 
laminin chain around the region of the proposed starting codon (34), 
a degenerate 5' primer based on the human sequence (sense: 5' 
TT(TC)(CGCT)GAGTT(TC)(AT)(GC)(CTG)TGG(CA)GGGG 3 '), 
and a 3' primer based on the published mouse sequence (antisense: 
5' GTCACAGAGCCATGTGCCCAC 3') were prepared. The prim-
ers were used in RT-PCR to amplify a fragment from total RNA of 
adult mouse lung. To correct for possible TAQ polymerase errors all 
sequences were determined from both strands and were repeated on 
clones obtained from independent PCR products. Database homology 
searches were performed on the BLAST server at the National Center 
for Biotechnology Information [35] and sequences were compared by 
FASTA at the European Bioinformatics Institute server [36]. 
2.2. Northern blot analysis and RNase protection assay 
Ten ug of total RNA isolated from the human kidney 293 cell line 
was electrophoresed on 0.8% denaturing agarose gels, transferred onto 
nylon membranes (Hybond N+, Amersham) and the membranes were 
incubated according to standard procedures with a [32P]dCTP-labeled 
probe corresponding to clone 10. A fibronectin-specific probe was 
used as a reference for mRNA size. 
A probe able to discriminate between oc3a and oc3b was prepared by 
RT-PCR from mammary gland total RNA (Clontech Laboratories, 
Inc.) (nucleotides 7-360 GenBank accession No. L34155) and cloned 
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into the pGEM-T vector (Promega). [32P]UTP-labeled antisense ri- 3. Results and discussion 
boprobes were synthesized from the SP6 promoter with 25 units of 
SP6 RNA polymerase (Promega) and hybridised overnight with total 
RNA (10 ug) extracted from a panel of 18 adult tissues (Clontech). 3 L Molecular cloning of the NHz-terminal region of the 
The degree of intactness and amount of input RNAs were ascertained human laminin a3 chain variant 
by adding a ß-actin probe. Post-hybridization procedures were per- Out of 30 clones obtained with the use of degenerate pri-
formed using the RPAII kit (Ambion). The RNase protected m e r s (deg_j a n d ¿ 2 ) two clones (clone 9 and clone 10) were 
fragments were run on a sequencing gel, autoradiographed and c , , ■ . , ,. .. , . . . . .. ■ • ■ j . ™ , c 
,, ■<- , .-r- . ■ <- -A A A * j. • round to yield distinct restriction patterns which dinered from 
the specific signals quantified by computer-aided densitometnc scan- 3 v 
n i n g those expected for the known oc chains. While the sequence of 
Fig. 1. A: Northern blot analysis of a3b mRNA. Each lane contained 10 u.g of total cellular RNA from the embryonal kidney 293 cell line. 
Lane 1 was hybridized with a a3b-specific probe and lane 2 with a fibronectin- (FN-) specific probe and the blot was exposed for 24 h. Stand-
ard size markers are shown on the left. B: Deduced amino acid sequence of the human oc3b chain variant NH2-terminal region. Cysteine resi-
dues are highlighted and potential glycosylation sites are boxed. The human sequence corresponding to the partial mouse sequence reported in 
C (lower row) is boxed in gray. The extension of the conventional laminin domains is indicated on the right [40,41]. The numbered arrows cor-
respond to primers used for PCR and RACE assays. The nucleotide sequence is available from EMBL under accession number AF005258. C: 
Partial nucleotide and deduced amino acid sequence of the mouse oc3B chain variant homologue. Upper row: the sequence reported by Gallia-
no et al. [34]; lower row: the sequence reported in this study. The arrow indicates the base pair that most likely caused the missense translation 
in [34] resulting in a start codon for methionine (encircled). 
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Fig. 2. A : Schematic domain structures of the human a3a and a3b chain variants in relation to the a5 laminin chain. The modules constitut-
ing the different domains are designated according to Bork [42]. Plain numbers refer to individual EGF-like modules, whereas encircled num-
bers correspond to the number of putative cysteines in each module. The number of spacing residues between the EGF modules are in bold. 
Arrowheads indicate the characteristic longer spacings unique to the cc3b and cc5 chains. B: Predicted evolutionary scheme modified from Min-
er et al. [25]. The numbers of intact EGF-like modules of each chain are indicated. 
clone 9 was highly homologous to that of the genuine murine 
a5 chain and likely corresponded to the human a5 chain, the 
sequence of clone 10 (780 bp) differed slightly from that of 
clone 9 and was related to but clearly distinct from those of 
the other known laminin chains. A second overlapping ampli-
fication product (clone 11) of 369 bp and extending toward 
the 3'-end was cloned from the same source using primer 1 
(see Fig. IB) derived from the sequence of clone 10 and one 
degenerate primer (deg-3). Therefore, we hypothesized that 
these amplification products could represent either part of a 
new oc chain or the presumptive NH2 -terminal region of a 
predicted variant full-sized oc3 form [37]. To test this second 
hypothesis 10 u,g of total RNA of the human fibrosarcoma 
cell line HS-913T was reversed transcribed using exanucleo-
tides and AMV RT (Promega) and PCR was performed with 
primer 2 in clone 11 and a primer in the published sequence of 
the human rx3b (nucleotides 301-320 as in GenBank accession 
No. L34156) using a long extension TAQ polymerase (Boehr-
inger Mannheim). A predominant band of about 3200 bp was 
reamplified with a nested primer and confirmed its identity. 
Overlapping digested fragments were then cloned in the 
pGEM-7zf(-) vector and sequenced. At the 3'-end the novel 
sequence overlapped by 320 bp the previously published oc3b 
sequence, confirming the gene product identity. With the 
RACE technique we could further extend the sequencing by 
about 200 bp towards the 5'-end of the a3b chain transcript. 
Northern blot analysis of total RNA purified from the 293 cell 
line and hybridized with a probe specific for the oc3b form 
identified one single band corresponding to a transcript of 
about 11 kb (Fig. 1A). The novel cDNA (Fig. IB) spans 
4458 bp and corresponds to an open reading frame of 1486 
amino acids. The first amino acid of the deduced sequence is 
an alanine indicating that the fragment does not embody the 
complete 5'-end of the coding sequence but it extends further 
upstream compared to murine oc3B variant published while 
this work was in progress [38]. Repeated efforts to utilize 
the RACE method for identifying these terminal residues 
have thus far been unsuccessful. 
3.2. Domain structure of the NHß-terminal region of cßb chain 
variant and comparison with other laminin a chains 
The laminin oc3b chain variant appears to belong to the 
group of a chains recently defined as 'full-sized' oe chains 
and including ocl, oc2, oc5 and ocD. At the amino acid level 
the highest homology is to the oc5 chain, followed by ocD, ocl 
and a2. First, a comparison with domain V of the oc5 chain 
(Fig. 2A) indicates that, in oc3b, the EGF-like modules 4, 5, 
and 6 are skipped and that EGF-like module 10 lacks the 
unpaired cysteine present in the corresponding module of 
the a5 chain. To rule out the existence of a transcript with 
a longer form of the V domain that could suggest alternative 
splicing of EGF-like modules 4, 5, and 6, a RT-PCR analysis 
using primers upstream and downstream the three skipped 
EGF-like modules was performed and in all the oc3b-contain-
ing tissues and cell lines only a single band of the size corre-
sponding to the a3b transcript originally isolated was ampli-
fied (data not shown). Second, another significant similarity 
between a3b and a5 chains is that the characteristic 2 amino 
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Fig. 3. A: Expression levels of a3a and a3b mRNAs as determined by RNase protection assay. Each lane contains the common probe plus 10 
ug of total RNA from the different adult tissues indicated. The products were run on 6% (w/v) sequencing gels and exposed at room tempera-
ture. B: Densitometric analysis of autoradiographs as illustrated in A. The optical density scale is in arbitrary units (a.u.) considering the a3a 
levels in placenta as the maximal optical density (100 a.u.). 
acid residues long interspacing of the EGF-like modules in 
laminins is interrupted in both a3b and oc5 chains between 
EGF-3 and EGF-4 by 23 residues and between EGF-8 and 
EGF-9 by 6 residues in oc3b and by 4 residues in a5. Third, a 
computer-aided analysis using the FASTA program refined 
manually in which the common regions of the a3, a4, and 
a5 chains were compared, indicated that also in the COOH-
terminal region the a3 chain was slightly more closely related 
to the oc5 than to the ocl-oc4 chains. Finally, based on the 
above analysis, the evolutionary scheme proposed by Miner 
et al. [25] may be modified as in Fig. 2B in which we propose 
that the truncated oc4 gene evolved separately from a common 
full-sized progenitor, which later duplicated originating a5 
and oc3. This evolutionary scheme is a likely possibility in 
view of the fact that repeated efforts to isolate a oc4 full-sized 
form have failed so far (Iivanainen, A., personal communica-
tion). 
3.3. Is there an intermediate form between the truncated a3A 
and the full-sized a3B? 
In a recent work, Galliano et al. [34] reported the primary 
structure of a mouse cc3B laminin chain lacking domains VI 
and V. Repeated unsuccessful attempts were made by us to 
isolate the corresponding variant from human tissues and cell 
lines. To determine whether the apparent discrepancy could 
be due to interspecies differences, the sequence around the 
predicted initiator ATG of the published mouse a3B chain 
was amplified from total RNA of adult mouse lung by RT-
PCR and a fragment of the expected length (360 bp) was 
obtained and found to differ by one guanine, just after the 
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beginning of the coding sequence (Fig. 1C). We next sought to 
investigate whether any a3 chain of intermediate size exists in 
the mouse and RNase protection experiments yielded a single 
protected band of a size corresponding to the long cc3B form 
(data not shown). In support of our data the mouse sequence 
of Galliano et al. [34] contained an unusual signal peptide, as 
the calculated score with the von Heijne algorithm [39] was 
much lower (—4.3) than the averaged score (about 10) for the 
known signal peptide sequences. This latter finding is consis-
tent with a recent study of Miner et al. (1997) reporting the 
cloning of a full-sized murine oc3B variant with a sequence 
identical to that determined by us in the region of discrep-
ancy. 
3.4. Differential expression of cßa and o3b chain RNAs in 
adult human tissues 
The extensive study of the expression of laminin a chains 
expression during mouse embryogenesis did not investigate 
the oc3a and oc3b variants separately [38]. Moreover, while a 
comparative tissue expression of the two forms by in situ 
hybridization was reported in selected murine tissues [34], 
no information is available about the relative ratios of the 
two a3 chain variants. We have used a riboprobe capable at 
discriminating between the a3a and oc3b transcripts (344 bp 
and 225 bp for a3a and a3b, respectively) in RNase protec-
tion assays on total RNA extracted from a broad panel of 
adult human tissues (Fig. 3A). This approach allowed for a 
precise and sensitive quantification of the ratios between the 
two transcripts in each tissue as well as for a semi-quantitative 
comparison of the expression levels of each of the RNAs in 
different tissues. The analysis of the relative amounts (Fig. 3B) 
of the two variants indicated that there are several patterns of 
expression: several tissues expressed neither oc3a nor oc3b; 
others expressed only the oi3b form; other tissues (spleen, 
stomach, kidney, skeletal muscle, pancreas, and adrenal 
gland) expressed similar levels of both forms ; salivary gland 
had only a3a. The amounts of a3a and a3b also vary con-
siderably among the positive tissues: placenta was by far the 
tissue with the highest levels of a3a and the uterus had the 
highest values of a3b. From this analysis it could be con-
cluded that while the oc3a variant is more represented in 
some epithelial tissues, the cc3b variant has a broader tissue 
expression pattern. 
4. Conclusions 
The a3a chain variant has been reported to exhibit unique 
biosynthetic characteristics, as the 200 kDa precursor poly-
peptide is processed extracellularly at both the NH2- and 
COOH-terminal ends, resulting in a mature form of 
145 kDa [27]. The exclusive presence of oc3b transcripts in 
some tissues makes it unlikely that this chain is processed 
in the same way as the oc3a. While the reciprocal func-
tion of these two a3 chain variants remains to be eluci-
dated, if the a3b chain variant corresponds to an unproc-
essed full-sized a chain retaining its N-terminal domains 
VI-IV intact, it may exhibit functional traits analogous to 
other 'full-sized' a chains such as self-assembly and odßl/ 
a2ßl integrin recognition. Finally, by sequence comparison 
between common regions and by domain structural features 
it appears that the cc3 cDNA is more closely related to oc5 
than to oc4. 
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